Dialysis patients were more likely than transplant recipients to die from pre-existing cancers, whereas transplant recipients were more likely to die from de novo cancers.
No difference in patient, graft survival; increased costs seen for A2 to B deceased donor kidney transplant
By 4 years after transplantation, cognitive scores were 5.8 points lower for frail vs nonfrail transplant recipients.
Increased-risk donors significantly more likely to have positive HBV, HCV screening results
In a nationwide study, renal transplant recipients with lupus nephritis had a 70% lower risk for all-cause mortality than nonrecipients.
Whole-exome sequencing-related molecular genetic diagnosis can have implications for clinical care
In a Japanese study, targeting high hemoglobin concentrations of 12.5-13.5 g/dL with erythropoiesis-stimulating agents resulted in longer graft survival.
Poor vitamin K status is associated with inflammation and low areal bone mineral density (BMD) among patients with end-stage renal disease.
The use of direct-acting antiviral agents to treat chronic HCV could allow for transplantation from donors HCV to recipients without the disease.
Also do not correlate well with reperfusion biopsies, not linked to transplant outcomes
Donor profile index of transplanted kidneys has risen modestly in US, with greater increase in France.
Study reveals an 11% prevalence of active gout among solid organ transplant recipients overall and a 13% prevalence among kidney transplant recipients.
In a study, kidney transplant recipients with a BMI (in kg/m2) higher than 35 have graft and patient outcomes similar to those with a BMI of 30 to 35.
Patients who lose 10% or more of their body weight from the time of their listing on a transplant waiting list are at higher risk of death following deceased-donor kidney transplantation.
Double-dose influenza vaccine is safe and may increase antibody response in solid-organ transplant recipients
Well-being and medication adherence negatively linked to psychological morbidity, dialysis.
Preemptively listed recipients have about four fewer years of pretransplant dialysis
Patient and graft survival are similar for patients who were on hemodialysis and peritoneal dialysis prior to transplantation.
Potential donors undergoing multidetector computed tomography during their assessment should be counseled on the medical implications of incidentally discovered lesions.
All 20 recipients experienced HCV cure, good quality of life, excellent renal function.
After 2000, investigators observed a deceleration in short-term improvements in graft survival.
Recipient social support most influential factor for providers concerned with avoiding organ wastage.
Increases quality-adjusted life expectancy, reduces costs versus transplant of HCV-uninfected kidney.
From pre- to post-expansion period, 59% relative increase in Medicaid-covered preemptive listings.
Associated with increased risk of composite end point of acute rejection, allograft failure.
Increased odds of using multiple sun protection measures among organ transplant recipients.
Delaying treatment until after transplant doesn't adversely impact kidney allograft or survival.
Other concerns expressed by living donors include surgical, lifestyle, psychosocial impact of donation.
No difference in survival between recipients of organs from drug-intoxicated donors, other donors.
A study found that bladder cancer and UTUC occurred in 122.22 and 113.97 per 100,000 persons per year, respectively, among kidney transplant recipients.
Renal and Urology News Articles
- Clinicians Somewhat Favor Shared Decision-Making in Older mCRPC Patients
- Higher Push-Up Capacity Linked to Lower Incidence of CVD Events
- Pembrolizumab Shows Promise for BCG-Unresponsive Bladder Cancer
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer
- Dialysis and Transplant Patients at Increased Risk for Cancer Death
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)